whitepaper
App Note: Faster and Easier Charge Heterogeneity Analysis with the iCE3
Three major usability improvements are now available for the iCE3 system...
List view / Grid view
Drug Discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
news
Cancer Research UK invests £15m to develop new cancer treatments
7 October 2015 | By Victoria White
The Cancer Research UK Centres Network Accelerator Award provides infrastructure support to research centres in order to encourage collaboration between different organisations and boost ‘bench to bedside’ science...
whitepaper
App Note: Total Protein Analysis the Simple Western Way
The Simple Western Immunoassay is the gel-free, blot-free and hands-free solution for those looking for a better way to get their Western blot data...
news
Horizon Discovery Group in-licenses oncology programme from Servier
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
news
Discovery could transform rheumatoid arthritis patient care
6 October 2015 | By Victoria White
Cardiff University immunologists have described how an immune system protein - interleukin-27 - regulates the inflammatory process in lymphoid-rich rheumatoid arthritis...
news
Nobel Prize recognises discoveries in parasitic diseases
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
news
Drug discovery initiative TaNeDS opens for applications
1 October 2015 | By Victoria White
The TaNeDS programme provides close partnership between successful applicants and scientists in Daiichi Sankyo to tackle unmet medical needs...
news
LDC and Infinity to work together on oncology drug discovery
29 September 2015 | By Victoria White
LDC and Infinity will work together to select high-potential cancer drug discovery projects from the LDC’s portfolio and its broad academic network...
news
New collaboration to interpret human proteome information
25 September 2015 | By Victoria White
The team of researchers will comprehensively study human proteomes with the aim of turning the vast amount of molecular information into designs for new reagents, equipment, workflows, assays and software...
news
Regeneron and ETI team up to discover monoclonal antibodies
24 September 2015 | By Victoria White
Regeneron will provide the ETI with access to VelocImmune technology to generate antibodies against targets of interest and explore potential therapeutic applications for human disease...
news
MRC Technology & University of Lausanne collaborate on MALT1 inhibitors
24 September 2015 | By Victoria White
Disregulation of MALT1 is associated with some subsets of lymphoma suggesting that MALT1 could be a promising drug target for these types of cancer...
news
MISSION Therapeutics receives funding for DUB cancer programme
24 September 2015 | By Victoria White
Deubiquitylating enzymes (DUBs) are involved in multiple cellular processes, including DNA damage and cell proliferation, and the inhibition of these enzymes has considerable potential for the generation of novel drugs...
news
H3 and Selvita extend precision cancer drug collaboration
22 September 2015 | By Victoria White
The companies are validating the druggability of two kinase targets in a specific genetic context and have generated multiple novel chemical series against these targets...
article
Drug Target Review – Issue #3 2015
21 September 2015 | By Drug Target Review
Included in this issue: Drug Development, Microfluidics, Proteomics, Ion Channels, GPCR, Imaging, Flow Cytometry, Enzymes
news
Dr Jeanette Wood joins Nuevolution as Scientific Advisor
21 September 2015 | By Victoria White
Dr Wood's expertise and experience to support Nuevolution in developing its pipeline in oncology, inflammation and immuno-oncology...
